tirzepatide pros and cons for weight loss vs. Semaglutide: What You Should Know Can Tirzepatide Help You Lose

Excess visceral fat increases the risk of serious health conditions such as heart disease, type 2 diabetes, and metabolic disorders

The cardiovascular effect of tirzepatide: a glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide dual agonist

The drug lowers body weight on top of improving glucose control, and clinicians sometimes use it off-label for weight management, though the label indication is for type 2 diabetes

Future research endeavors should prioritize identifying the variables responsible for heterogeneity in meta-regression analyses, including factors such as gender, drug dosage, and study duration, which can impact changes in HbA1c and weight

Many insurance plans now recognize documented semaglutide failure as a valid reason to approve tirzepatide coverage, particularly for patients with type 2 diabetes or BMI above 30